Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: November 3, 2026 at 11:08 PM UTC
| NCT Number | NCT07365241 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 531 participants |
| Active Locations | 37 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 23, 2026 (Sep 23, 2026) |
As of November 3, 2026: Clinical trial NCT07365241 is currently recruiting participants. This phase3 study for small cell lung cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07365241 is actively recruiting participants as of November 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07365241 was last updated Sep 23, 2026 (September 23, 2026). HelloStudys verifies this status automatically.